SBIR TOPIC 294 PHASE 1 - DEVELOPMENT OF GLYCOSYLATION - SPECIFIC RESEARCH
SBIR TOPIC 294 PHASE 1 - DEVELOPMENT OF GLYCOSYLATION - SPECIFIC RESEARCH
批准号:
8354013
负责人:
BILL JACKSON
金额:
$14.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-15 至 2012-06-14
关键词:
AffinityAmino AcidsAntibodiesCancer BiologyCarbohydratesDNADevelopmentGenetic TranscriptionGlycobiologyGlycopeptidesGlycoproteinsImageLigandsLinkMalignant NeoplasmsMass Spectrum AnalysisMethodsModificationPhasePhosphorylationProtein AnalysisProteinsReagentResearchSignal TransductionSiteSmall Business Innovation Research GrantSurface Plasmon ResonanceTimeTumor Suppressor GenesUnited States National Institutes of Healthaptamerglycosylationinstrumentlink proteinnovelpolypeptidetool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The carbohydrate modification O-GlcNAc is nearly as abundant as protein phosphorylation in proteins, competes with it, and has extensive crosstalk to regulate signaling, transcription, and the functions of oncogenes and tumor suppressors. However, analysis of protein O-GlcNAcylation currently requires difficult and time-consuming methods such as sophisticated mass spectrometry. There is a need to develop new reagents and simpler methods to study the function of carbohydrate modifications (O-linked and N-linked) of proteins in cancer biology.¿
Even in labs with the ability to make glycosylation-specific antibodies, it is simply too time-consuming and expensive to do that on a scale which would have an impact on the field. DNA aptamers, on the other hand, are readily synthesized and at least 10 times less expensive than antibodies.
This project utilizes a new tool, ¿parallel selection of DNA aptamers¿ to rapidly identify high-affinity ligands to tens or even hundreds of glycoprotein or modified polypeptide targets simultaneously. In this NIH Phase I SBIR project, we will demonstrate the utility of our tool for selecting aptamers to numerous important glycoproteins implicated in cancer biology. We will also develop high affinity reagents to specific glycopeptides which are likely to find enormous utility in the understanding of cancer glycobiology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金